Medivir AB (publ) Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Magnus Christensen, was filed 30 May 2024.
Medivir AB (publ): what insiders have been doing
Medivir AB (publ) is a listed company. Filings by its managers are published through Finansinspektionen. No insider at Medivir AB (publ) has published a filing in the past twelve months. The most recent one dates from 30 May 2024.
Since 2023, the database holds 4 purchases and no sales by insiders of the company.
For comparison within the same market, see the insider buying recorded at Dynavox Group AB and Rusta AB (publ). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Financial data
· cache
- 15,000 shares@ SEK 2.9425.7% of flowAktieISIN SE0020181014FI:csv-fdb432673f9bd1fab8d8Canonical exit: 27 Aug 2024 (T+90)
- 12,000 shares@ SEK 7.34100.0% of flowAktieISIN SE0020181014FI:csv-81c917613d52e49f4d3dCanonical exit: 14 Aug 2023 (T+90)
- 17,000 shares@ SEK 7.3474.3% of flowAktieISIN SE0020181014FI:csv-4e4f82700bb31bc61ea5Canonical exit: 14 Aug 2023 (T+90)
- 17,000 shares@ SEK 7.34100.0% of flowAktieISIN SE0020181014FI:csv-4af2450d56b9c5926516Canonical exit: 14 Aug 2023 (T+90)
4 of 4 declarations
About Medivir AB (publ)
Medivir AB (publ) is a Swedish biopharmaceutical company focused on developing antiviral treatments. It is listed on the Stockholm Stock Exchange under the symbol XSTO.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations